Allison Hagerman insider trades

Open-market stock purchases and sales by Allison Hagerman, Chief Technology Officer at Oncolytics Biotech Inc, from SEC Form 4 filings since Feb 12, 2026.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -40%.

Recent trades

DateStockTradeValue
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Feb 12, 2026ONCY Oncolytics Biotech IncBought$8.3K

Companies traded

  • ONCY Oncolytics Biotech Inc: 1 buy, last Jun 1, 2026

Get free alerts when Allison Hagerman files a new trade →